Acurx Pharmaceuticals, Inc.

  • Home
  • About
    • Management / Consultants
    • Scientific / Corporate Advisors
    • Board of Directors
  • Pipeline
    • Overview
    • Ibezapolstat
    • GPSS™
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Videos
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Ph2 Clinical Trial
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Videos

Acurx Announces Presentation and Update of Its pol IIIC R&D Pipeline at the World Antimicrobial Resistance Scientific Congress

Sep 12, 2023

Acurx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023

Aug 22, 2023

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update

Aug 14, 2023

Acurx Pharmaceuticals to Discuss Second Quarter 2023 Financial Results and Provide Business Update

Jul 24, 2023

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on July 12, 2023

Jun 20, 2023

Acurx Pharmaceuticals to Participate in the Maxim Group LLC Virtual Healthcare Conference on Tuesday, June 20, 2023 to Thursday, June 22, 2023 at 9 am ET

Jun 15, 2023

Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering

May 16, 2023

Acurx Pharmaceuticals, Inc. Reports First Quarter 2023 Results and Provides Business Update

May 12, 2023

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update

May 5, 2023

Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference

Apr 19, 2023
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
© 2023 Acurx Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap